Home  »  Company  »  Aurobindo Pharma Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Aurobindo Pharma Ltd. Company

(Rs in Cr.) Mar 31, 2023 Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019
Operating Income 12,792.28 11,287.14 15,823.68 13,266.48 12,257.89
Manufacturing Expenses 613.92 477.99 512.34 520.30 505.96
Personnel Expenses 1,641.88 1,600.04 1,735.42 1,561.47 1,362.77
Selling Expenses 0 0 0 0 0
Administrative Expenses 1,795.57 1,754.34 2,030.53 1,806.54 1,616.92
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 11,061.36 9,813.74 11,703.85 10,580.73 9,848.60
Operating Profit 1,730.92 1,473.40 4,119.83 2,685.75 2,409.29
Other Recurring Income 433.76 670.99 589.86 403.37 199.22
Adjusted PBDIT 2,164.68 2,144.39 4,709.69 3,089.12 2,608.51
Financial Expenses 114.98 16.94 28.68 240.94 230.86
Depreciation 435.35 415.26 488 470.48 413.03
Other Write offs 0 0 0 0 0
Adjusted PBT 1,614.35 1,712.19 4,193.01 2,377.70 1,964.62
Tax Charges 383.94 182.77 1,080.10 504.96 434.89
Adjusted PAT 1,230.41 1,529.42 3,112.91 1,872.74 1,529.73
Non Recurring Items 5.87 -73.02 -6.42 0 0
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 1,230.41 1,454.71 3,112.91 1,872.74 1,529.73
Equity Dividend 439.45 263.67 234.38 166.12 132.62
Preference Dividend 0 0 0 0 0
Retained Earnings 16,660.97 15,864.14 14,671.41 11,857.09 10,173.99
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X